CQT — Conneqt Health Share Price
Last trade - 00:00- AU$14.85m
- AU$16.09m
- AU$3.55m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 23.44 | ||
| Price to Tang. Book | 126.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.18 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -974.41% | ||
| Return on Equity | -770.77% | ||
| Operating Margin | -359.96% | ||
Financial Summary
| Year End 30th Jun | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 5.26 | 4.5 | 4.86 | 11.18 | 3.55 | n/a | n/a | -5.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Conneqt Health Limited, formerly CardieX Limited, is an Australia-based digital health technology company that develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. The Company's suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular diseases, and other vascular health disorders, all based on its SphygmoCor vascular biomarker technology. Its SphygmoCor vascular biosensing technology measures arterial health by collecting clinically meaningful digital vascular biomarkers using novel sensors. These biomarkers represent key indicators of cardiovascular health including central blood pressures, vascular stiffness, vascular age, and heart stress. It offers CONNEQT, which is a clinical-grade arterial assessment that provides professional-level arterial health insights.
Directors
- Niall Cairns CHM
- Craig Cooper CEO
- Jarrod White CFO
- Chris Dax CEX
- Rhonda Welch VPR
- Douglas Kurschinski GMG
- Mark Harding OTH
- Nicholas Marshall SEC
- Randall Nelson NID
- Last Annual
- June 30th, 2025
- Last Interim
- June 30th, 2025
- Incorporated
- March 7th, 2005
- Public Since
- November 9th, 2005
- No. of Employees
- 26
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 550,080,317
- Address
- Suite 301, 55 Lime St, Barangaroo, SYDNEY, 2000
- Web
- https://cardiex.com/
- Phone
- +61 298748761
- Auditors
- BDO Audit Pty Ltd
Similar to CQT
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
Atomo Diagnostics
Australian Stock Exchange - SEATS
FAQ
As of Today at 20:03 UTC, shares in Conneqt Health are trading at AU$0.03. This share price information is delayed by 15 minutes.
Shares in Conneqt Health last closed at AU$0.03 and the price had moved by -63.18% over the past 365 days. In terms of relative price strength the Conneqt Health share price has underperformed the ASX All Ordinaries Index by -65.83% over the past year.
There is no consensus recommendation for this security.
Find out moreConneqt Health does not currently pay a dividend.
Conneqt Health does not currently pay a dividend.
Conneqt Health does not currently pay a dividend.
To buy shares in Conneqt Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.03, shares in Conneqt Health had a market capitalisation of AU$14.85m.
Here are the trading details for Conneqt Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CQT
Based on an overall assessment of its quality, value and momentum Conneqt Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Conneqt Health. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -58.95%.
As of the last closing price of AU$0.03, shares in Conneqt Health were trading -57.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Conneqt Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Conneqt Health's management team is headed by:
- Niall Cairns - CHM
- Craig Cooper - CEO
- Jarrod White - CFO
- Chris Dax - CEX
- Rhonda Welch - VPR
- Douglas Kurschinski - GMG
- Mark Harding - OTH
- Nicholas Marshall - SEC
- Randall Nelson - NID